Chromatin Remodelling and Immunity: Volume 106

Chromatin Remodelling and Immunity: Volume 106

Series edited by 

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?


Chromatin Remodelling and Immunity, Volume 106, the latest release in the Advances in Protein Chemistry and Structural Biology series is an essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related more

Product details

  • Hardback | 318 pages
  • 152 x 229 x 19.05mm | 660g
  • Elsevier Science Publishing Co Inc
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0128123923
  • 9780128123928

Table of contents

Chromatin Remodeling in Monocyte and Macrophage ActivationJ.L. SchultzeRoles of SMC Complexes During T Lymphocyte Development and FunctionJ.S. RawlingsThe Role of Epigenetic Regulation in Transcriptional Memory in the Immune SystemA.M. Woodworth and A.F. HollowayHistone Acetylation and the Regulation of Major Histocompatibility Class II Gene ExpressionK. Suzuki and Y. LuoMechanisms of Chromatin Remodeling and Repurposing During Extracellular TranslocationD.S. PisetskyEpigenetic Changes in Chronic Inflammatory DiseasesO. Fogel, C. Richard-Miceli and J. TostRegulation of Cellular Immune Responses in Sepsis by Histone ModificationsW.F. Carson IV and S.L. KunkelA New Molecular Mechanism Underlying the Anti-Tumor Effect of DNA Methylation Inhibitors Via an Anti-Viral Immune ResponseY. Saito, T. Nakaoka and H. SaitoChromatin Remodeling and Plant ImmunityW. Chen, Q. Zhu, Y. Liu and Q. Zhangshow more

About Rossen Donev

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2010 Dr. Donev was appointed Lecturer in Swansea University. Currently he is Director of Biomed Consult Ltd, UK. His major research interests include signalling pathways involved in neuropsychiatric disorders and tumour escape from the immune system, and development of therapeutic strategies for treatment. He has published more than 50 research papers, has chaired scientific meetings in Molecular Medicine and given plenary talks at Attention Deficit/Hyperactivity Disorder meetings. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other more